Search Results

There are 33605 results for: content related to: Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

  1. Immunohistochemical profiles of IDH1, MGMT and P53: Practical significance for prognostication of patients with diffuse gliomas

    Neuropathology

    Volume 35, Issue 4, August 2015, Pages: 324–335, Ryosuke Ogura, Yoshihiro Tsukamoto, Manabu Natsumeda, Mizuho Isogawa, Hiroshi Aoki, Tsutomu Kobayashi, Seiichi Yoshida, Kouichiro Okamoto, Hitoshi Takahashi, Yukihiko Fujii and Akiyoshi Kakita

    Version of Record online : 6 MAY 2015, DOI: 10.1111/neup.12196

  2. You have free access to this content
    O6-methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma

    International Journal of Cancer

    Volume 137, Issue 6, 15 September 2015, Pages: 1291–1305, Shang Hung Chen, Ching Chuan Kuo, Chien Feng Li, Chun Hei Antonio Cheung, Tsui Chun Tsou, Huai Chih Chiang, Yun Ning Yang, Shin Lun Chang, Li Ching Lin, Hsin Yi Pan, Kwang Yu Chang and Jang Yang Chang

    Version of Record online : 6 MAR 2015, DOI: 10.1002/ijc.29486

  3. You have free access to this content
    MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations

    International Journal of Cancer

    Volume 131, Issue 5, 1 September 2012, Pages: 1104–1113, Shani Mulholland, Danita M. Pearson, Rifat A. Hamoudi, Deborah S. Malley, Caroline M. Smith, Jamie M.J. Weaver, David T.W. Jones, Sylvia Kocialkowski, L. Magnus Bäcklund, V. Peter Collins and Koichi Ichimura

    Version of Record online : 11 JAN 2012, DOI: 10.1002/ijc.26499

  4. You have free access to this content
    MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma

    International Journal of Cancer

    Volume 127, Issue 9, 1 November 2010, Pages: 2106–2118, Markus Christmann, Georg Nagel, Sigrid Horn, Ulrike Krahn, Dorothee Wiewrodt, Clemens Sommer and Bernd Kaina

    Version of Record online : 3 FEB 2010, DOI: 10.1002/ijc.25229

  5. You have free access to this content
    Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol

    International Journal of Cancer

    Volume 118, Issue 3, 1 February 2006, Pages: 527–531, Rana Abdel-Fattah, Adam Glick, Ishtiaq Rehman, Patrick Maiberger and Henry Hennings

    Version of Record online : 10 AUG 2005, DOI: 10.1002/ijc.21316

  6. You have free access to this content
    O6-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation

    International Journal of Cancer

    Volume 84, Issue 4, 20 August 1999, Pages: 416–420, Christine Rolhion, Frédérique Penault-Llorca, Jean-Louis Kemeny, Fabrice Kwiatkowski, Jean-Jacques Lemaire, Philippe Chollet, Françoise Finat-Duclos and Pierre Verrelle

    Version of Record online : 10 NOV 1999, DOI: 10.1002/(SICI)1097-0215(19990820)84:4<416::AID-IJC15>3.0.CO;2-A

  7. You have free access to this content
    Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

    International Journal of Cancer

    Volume 131, Issue 6, 15 September 2012, Pages: 1342–1350, Guido Reifenberger, Bettina Hentschel, Jörg Felsberg, Gabriele Schackert, Matthias Simon, Oliver Schnell, Manfred Westphal, Wolfgang Wick, Torsten Pietsch, Markus Loeffler, Michael Weller and for the German Glioma Network

    Version of Record online : 11 JAN 2012, DOI: 10.1002/ijc.27385

  8. You have full text access to this Open Access content
    Epigenetic aberrations and therapeutic implications in gliomas

    Cancer Science

    Volume 101, Issue 6, June 2010, Pages: 1331–1336, Atsushi Natsume, Yutaka Kondo, Motokazu Ito, Kazuya Motomura, Toshihiko Wakabayashi and Jun Yoshida

    Version of Record online : 15 MAR 2010, DOI: 10.1111/j.1349-7006.2010.01545.x

  9. You have free access to this content
    MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma

    International Journal of Cancer

    Volume 136, Issue 12, 15 June 2015, Pages: 2844–2853, Rainer Tuominen, Rosalyn Jewell, Joost J. van den Oord, Pascal Wolter, Ulrika Stierner, Christer Lindholm, Carolina Hertzman Johansson, Diana Lindén, Hemming Johansson, Marianne Frostvik Stolt, Christy Walker, Helen Snowden, Julia Newton-Bishop, Johan Hansson and Suzanne Egyházi Brage

    Version of Record online : 24 NOV 2014, DOI: 10.1002/ijc.29332

  10. Inactivation of O6-methyguanine-DNA methyltransferase by promoter hypermethylation: Association of epithelial ovarian carcinogenesis in specific histological types

    Journal of Obstetrics and Gynaecology Research

    Volume 37, Issue 7, July 2011, Pages: 851–860, Hyun-Jin Roh, Dong-Soo Suh, Kyung-Un Choi, Hang-Jo Yoo, Won-Deok Joo and Man-Soo Yoon

    Version of Record online : 31 MAR 2011, DOI: 10.1111/j.1447-0756.2010.01452.x

  11. The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations

    Brain Pathology

    Volume 21, Issue 1, January 2011, Pages: 74–87, Andreas Von Deimling, Andrey Korshunov and Christian Hartmann

    Version of Record online : 3 DEC 2010, DOI: 10.1111/j.1750-3639.2010.00454.x

  12. You have free access to this content
    The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma

    International Journal of Cancer

    Volume 119, Issue 2, 15 July 2006, Pages: 264–268, S. Baumann, G. Keller, F. Pühringer, R. Napieralski, M. Feith, R. Langer, H. Höfler, H. J. Stein and M. Sarbia

    Version of Record online : 13 FEB 2006, DOI: 10.1002/ijc.21848

  13. You have free access to this content
    Repair of DNA lesion O6-methylguanine in hepatocellular carcinogenesis

    Journal of Hepato-Biliary-Pancreatic Surgery

    Volume 5, Issue 4, December 1998, Pages: 355–366, Glenn N. Major and Jane D. Collier

    Version of Record online : 1 DEC 1998, DOI: 10.1007/s005340050059

  14. Prognostic value of O-6-methylguanine-DNA methyltransferase loss in salivary gland carcinomas

    Head & Neck

    Volume 36, Issue 9, September 2014, Pages: 1258–1267, Asta Scesnaite, Sonata Jarmalaite, Maximillian Mueller, Abbas Agaimy, Johannes Zenk, Arndt Hartmann, Heinrich Iro, Brigitte Peters, Stephan Schwarz and Regine Schneider–Stock

    Version of Record online : 27 NOV 2013, DOI: 10.1002/hed.23445

  15. Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker

    Brain Pathology

    Volume 18, Issue 4, October 2008, Pages: 520–532, Matthias Preusser, Robert Charles Janzer, Jörg Felsberg, Guido Reifenberger, Marie-France Hamou, Annie-Claire Diserens, Roger Stupp, Thierry Gorlia, Christine Marosi, Harald Heinzl, Johannes A Hainfellner and Monika Hegi

    Version of Record online : 8 APR 2008, DOI: 10.1111/j.1750-3639.2008.00153.x

  16. You have free access to this content
    Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene mgmt

    International Journal of Cancer

    Volume 92, Issue 1, 1 April 2001, Pages: 123–129, Markus Christmann, Matthias Pick, Hermann Lage, Dirk Schadendorf and Bernd Kaina

    Version of Record online : 7 FEB 2001, DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1160>3.0.CO;2-V

  17. The expression of O6-methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline

    Journal of Oral Pathology & Medicine

    Volume 42, Issue 8, September 2013, Pages: 600–605, Shiuan-Shinn Lee, Chung-Hung Tsai, Cheng-Chia Yu, Yung-Chuan Ho, Hsin-I Hsu and Yu-Chao Chang

    Version of Record online : 21 DEC 2012, DOI: 10.1111/jop.12037

  18. MGMT as a potential stratification marker in relapsed high-grade glioma of children: The HIT-GBM experience

    Pediatric Blood & Cancer

    Volume 54, Issue 2, February 2010, Pages: 228–237, Sabrina Schlosser, Sabine Wagner, Jörg Mühlisch, Martin Hasselblatt, Joachim Gerß, Johannes E.A. Wolff and Michael C. Frühwald

    Version of Record online : 23 OCT 2009, DOI: 10.1002/pbc.22323

  19. Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

    Clinical Endocrinology

    Volume 71, Issue 2, August 2009, Pages: 226–233, Ann I. McCormack, Kerrie L. McDonald, Anthony J. Gill, Susan J. Clark, Morton G. Burt, Kirsten A. Campbell, Wilton J. Braund, Nicholas S. Little, Raymond J. Cook, Ashley B. Grossman, Bruce G. Robinson and Roderick J. Clifton-Bligh

    Version of Record online : 3 DEC 2008, DOI: 10.1111/j.1365-2265.2008.03487.x

  20. Unraveling the Glioma Epigenome—From Molecular Mechanisms to Novel Biomarkers and Therapeutic Targets

    Brain Pathology

    Volume 21, Issue 6, November 2011, Pages: 619–632, Bastian Malzkorn, Marietta Wolter, Markus J. Riemenschneider and Guido Reifenberger

    Version of Record online : 13 OCT 2011, DOI: 10.1111/j.1750-3639.2011.00536.x